1. Introduction

   • H. Lode

   Interview 15 December 2012 Pages: 1 - 2

2. Importance of β- Lactamases and Clinical Implications of their Inhibitors

   • J. D. Williams

   Problems of Resistance in clinical Infection 15 December 2012 Pages: 3 - 11

3. β-Lactamases in Clinical Isolates Spectrum Implications of Sulbactam/Ampicillin

   • J. F. Acar
   • L. Gutmann
   • M.-D. Kitzis

   Problems of Resistance in clinical Infection 15 December 2012 Pages: 12 - 16

4. In Vitro Evaluations of Aminopenicillin/β-Lactamase Inhibitor Combinations

   • Ronald N. Jones

   Problems of Resistance in clinical Infection 15 December 2012 Pages: 17 - 26

5. Discussion — Problems of Resistance in Clinical Infections

   Problems of Resistance in clinical Infection 15 December 2012 Pages: 27 - 28

6. Comparative Pharmacokinetics of Sulbactam/ Ampicillin and Clavulanic Acid/Amoxycillin in Human Volunteers

   • B. Hampel
   • H. Lode
   • P. Koeppe

   Section 2: Pharmacology of Sulbactam 15 December 2012 Pages: 29 - 33

7. Discussion — Pharmacology of Sulbactam

   Section 2: Pharmacology of Sulbactam 15 December 2012 Pages: 34 - 34

8. Sulbactam/Ampicillin in Paediatric Infections

   • Adnan S. Dajani

   Section 3: Clinical Profiles of Sulbactam/Ampicillin 15 December 2012 Pages: 35 - 38

9. Sulbactam/Ampicillin versus Cefoxitin for Uncomplicated and Complicated Acute Pelvic Inflammatory Disease

   • D. L. Hemsell
   • M. C. Heard
   • B. J. Nobles

   Section 3: Clinical Profiles of Sulbactam/Ampicillin 15 December 2012 Pages: 39 - 42

10. Discussion — Clinical Profiles of Sulbactam/Ampicillin

    Section 3: Clinical Profiles of Sulbactam/Ampicillin 15 December 2012 Pages: 43 - 45

11. Sulbactam/Ampicillin versus Cefotaxime as Initial Therapy in Serious Soft Tissue, Joint and Bone Infections

    • L. Löffler
    • A. Bauernfeind
    • W. Keyl

    Section 3: Clinical Profile of Sulbactam/Ampicillin 15 December 2012 Pages: 46 - 52

12. Sulbactam/Ampicillin in the Treatment of Lower Respiratory Infections

    • M. A. Castellano

    Section 3: Clinical Profile of Sulbactam/Ampicillin 15 December 2012 Pages: 53 - 56

13. Clinical Experience with Intramuscular Sulbactam/Ampicillin in the Outpatient Treatment of Various Infections A Multicentre Trial

    • M. F. Güneren

    Section 3: Clinical Profile of Sulbactam/Ampicillin 15 December 2012 Pages: 57 - 68

14. Discussion — Clinical Profiles of Sulbactam/Ampicillin

    Section 3: Clinical Profile of Sulbactam/Ampicillin 15 December 2012 Pages: 69 - 70

15. Sulbactam and Clavulanic Acid: Studies of Enzyme Kinetics and Synergy with Ampicillin and Mezlocillin

    • W. Cullmann
    • M. Stieglitz
    • W. Opferkuch

    Short Communication 15 December 2012 Pages: 71 - 76

16. Sulbactam/Ampicillin in the Treatment of Epidemic Meningococcal Meningitis in Northern Nigeria

    • A. I. Dutse
    • Y. M. Fakunle
    • C. S. S. Bello

    Posters 15 December 2012 Pages: 77 - 79

17. Clinical and Pharmacokinetic Studies of Sulbactam/Penicillin Combinations in the Treatment of Ear, Nose and Throat Infections

    • P. Federspil
    • M. Schedler
    • E. Tiesler

    Posters 15 December 2012 Pages: 80 - 83

18. Ampicillin plus Sulbactam

    • F. Heilmann
    • W. Heizmann
    • H. Werner

    Posters 15 December 2012 Pages: 84 - 88

19. An Open Evaluation Study of Sulbactam/Ampicillin with or without Probenecid in the Treatment of Gonococcal Infections in Lagos

    • Tolu Odugbemi

    Posters 15 December 2012 Pages: 89 - 91

20. Use of Sulbactam/Ampicillin in the Treatment of Uncomplicated Gonococcal Infection

    • N. A. Rotowa
    • M. C. Asuzu
    • A. Osoba

    Posters 15 December 2012 Pages: 92 - 93

21. Closing Remarks

    • H. Lode

    Posters 15 December 2012 Pages: 94 - 94